Serotonin 5-HT1DB gene's interaction with key brain regions in obsessive-compulsive disorder

Klinik Psikofarmakoloji Bulteni

Volumn 20, Issue 1, 2010, Pages 23-28

  Atmaca, Murad ^a   Onalan, Ebru ^a   Yildirim, Hanefi ^a   Yuce, Huseyin ^a   Koc, Mustafa ^a   Korkmaz, Sevda ^a   Kara, Bilge ^a   Ozler, Sinan ^a   Mermi, Osman ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

G allele; MRI; OCD; OFC; Thalamus

Indexed keywords

SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MALE; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; RECEPTOR GENE; THALAMUS; VENOUS BLOOD; VOLUMETRY;

EID: 77957165382     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: 10.1080/10177833.2010.11790630     Document Type: Article

References (33)

1. Demet MM. Obsesif kompulsif bozuklukta genetik çalişmalar. Klinik Psikofarmakoloji Bülteni 2005;15:45-52.
2. Yaşan A, Gürgen F. Obsesif kompulsif bozuklukta elektroensefalografi bulgulari. Klinik Psikofarmakoloji Bülteni 2004; 14:61-67.
3. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res 2004;132:69-79.
4. Scarone S, Colombo C, Livian S, Abbruzzese M, Ronchi P, Locatelli M, Scotti G, Smeraldi E. Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res 1992; 45:115-121.
5. Robinson D, Wu H, Munne RA, Ashtari M, Alvir JM, Lerner G, Koreen A, Cole K, Bogerts B. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry 1995;52:393-398.
6. Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lencz T, Ashtari M, Wu H, Bogerts B. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Arch Gen Psychiatry 1999;56:913-919. (Pubitemid 29480127)
7. Jenike MA, Breiter HC, Baer L, Kennedy DN, Savage CR, Olivares MJ, O'Sullivan RL, Shera DM, Rauch SL, Keuthen N, Rosen BR, Caviness VS, Filipek PA. Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 1996;53:625-632.
8. O'Sullivan RL, Rauch SL, Breiter HC, Grachev ID, Baer L, Kennedy DN, Keuthen NJ, Savage CR, Manzo PA, Caviness VS, Jenike MA. Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry 1997;42:39-45. (Pubitemid 27293534)
9. Bartha R, Stein MB, Williamson PC, Drost DJ, Neufeld RW, Carr TJ, Canaran G, Densmore M, Anderson G, Siddiqui AR. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 1998;155:1584-1591. (Pubitemid 28512029)
10. Rosenberg DR, Benazon NR, Gilbert A, Sullivan A, Moore GJ. Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy. Biol Psychiatry 2000;48:294-300. (Pubitemid 30645799)
11. Riffkin J, Yucel M, Maruff P, Wood SJ, Soulsby B, Olver J, Kyrios M, Velakoulis D, Pantelis C. A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia. Psychiatry Res 2005;138:99-113.
12. Atmaca M, Yildirim H, Ozdemi, H, Tezcan E, Poyraz AK. Volumetric MRI study of key brain regions implicated in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:46-52. (Pubitemid 44959238)
13. Atmaca M, Yildirim H, Ozdemir H, Aydin A, Tezcan E, Ozler S. Volumetric MRI assessment of brain regions in patients with refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1051-1057. (Pubitemid 43928215)
14. Tot S, Erdal ME, Yazici K, Yazici AE, Metin O. T102C and -1438 G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder. Eur Psychiatry 2003;18: 249-254. (Pubitemid 37010317)
15. Frisch A, Michaelovsky E, Rockah R, Amir I, Hermesh H, Laor N, et al., Association between obsessive compulsive-disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol 2000;10:205-209.
16. Nicolini H, Cruz C, Camarena B, Orozco B, Kennedy JL, King N, Weissbecker K, de la Fuente JR, Sidenberg D. DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry 1996;1:461-465.
17. Mundo E, Richter MA, Sam F, Macciardi F, Kennedy JL. Is the 5-HT1Dβ Receptor Gene Implicated in the Pathogenesis of Obsessive-Compulsive Disorder? Am J Psychiatry 2000;157:1160-1161.
18. Mundo E, Richter MA, Zai G, Sam F, McBride J, Macciardi F, Kennedy JL. 5HT1Dbeta receptor gene implicated in the pathogenesis of obsessive-compulsive disorder: further evidence from a family-based association study. Mol Psychiatry 2002;7:805-809. (Pubitemid 34984961)
19. Camarena B, Nicolini H. Family-based association analysis of 5-HT1Db receptor gene in obsessive-compulsive disorder. Int J Neuropsychopharmacol 2002;5:116.
20. Corapçioǧlu A, Aydemir O, Yildiz M Esen A, Köroǧlu E. DSM-IV Eksen I Bozukluklari (SCID-I) İçin Yapilandirilmiş Klinik Görüşme, Klinik Versiyon. Hekimler Yayin Birliǧi, Ankara 1999.(inTurkish).
21. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale II. Validity. Arch Gen Psychiatry 1989;46:1012-1016.
22. Yuh WTC, Tali ET, Afifi AK, Sahinoglu K, Gai F, Bergman RA. MRI of Head & Neck Anatomy, Churchill Livingstone, 1994, New York.
23. Jackson GD, Duncan JS. MRI Anatomy: ANew Angle on the Brain, Churchill Livingstone, 1996, New York.
24. Patel VH, Friedman L. MRI of the Brain: Normal Anatomy and Normal Variants, WB Saunders Company, 1997. Philadelphia.
25. Noga JT, Aylward E, Barta PE, Pearlson GD. Cingulate gyrus in schizophrenic patients and normal volunteers. Psychiatry Res 1995;61:201-208.
26. Portas CM, Goldstein JM, Shenton ME, Hokama HH, Wible CG, Fischer I, Kikinis R, Donnino R, Jolesz FA, McCarley RW. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry 1998;43:649-649.
27. Lacerda AL, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Anatomical MRI study of basal ganglia in major depressive disorder. Psychiatry Res 2003;124:129-140.
28. Sassi RB, Brambilla P, Hatch MA, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC. Reduced left anterior cingulate volumes in untreated bipolar patients. Biol Psychiatry 2004;56:467-475. (Pubitemid 39278243)
29. Marziniak M, Mössner R, Kienzler C, Riederer P, Lesch KP, Sommer C. Functional polymorphisms of the 5-HT1A and 5-HT1B receptor are associated with clinical symptoms in migraineurs. J Neural Transmission 2007;114:1227-1232. (Pubitemid 47313165)
30. Gross R, Sasson Y, Chopra M, Zohar J. Biological models of obsessive-compulsive disorder. The serotonin hypothesis. In: Swinson RP, Antony MM, Rachman S, Richter MA (eds). Obsessive-Compulsive Disorder, Theory, Research and Treatment The Guilford Press: NY, 1998, 147-148.
31. Stein DJ, Van Heerden B, Wessels CJ, Van Kradenburg J, Warwick J, Wasserman HJ. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin autoreceptor. Prog Neuropsychopharmacol Biol Psychiatry 1999;23:1079-1099. (Pubitemid 29468915)
32. Koran LM, Pallanti S, Quercioli L. Sumatriptan, 5-HT1D receptors and obsessive-compulsive disorder. Eur Neuropsychopharmacol 2001;11:169-172. (Pubitemid 32335559)
33. Stern L, Zohar J, Cohen R, Sasson Y. Treatment of severe, drug resistant obsessive-compulsive disorder with the 5HT1D agonist sumatriptan. Eur Neuropsychopharmacol 1998;8:325-328. (Pubitemid 28557029)